查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1828234

2025年全球智慧切片检查设备市场报告

Smart Biopsy Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，智慧切片检查设备市场呈现强劲成长势头，市场规模将从2024年的28.5亿美元成长至2025年的30.1亿美元，复合年增长率为5.6%。预测期内的成长归因于癌症患者数量的增加、对微创手术的需求、医疗设备的创新以及诊断准确性的提高。

预计未来几年智慧切片检查设备市场将强劲成长，到2029年将达到40.1亿美元，复合年增长率为7.4%。预测期内的成长归因于个人化医疗的发展、诊断影像模式的进步、切片检查在生物标记分析中的应用增加、新参与企业的进入以及数据连接性的增强。预测期内的主要趋势包括机器人辅助切片检查、人工智慧辅助切片检查、无线切片检查工具的开发、可携式手持设备和即时引导系统。

智慧切片检查设备是一种智慧仪器，旨在提高医疗过程中组织取样的准确性和效率，通常包含影像引导、即时回馈和机器人辅助等功能。这些设备旨在提高诊断能力和患者预后，尤其是在癌症诊断和药物传输方面。

智慧切片检查设备类别的关键产品包括针切片检查设备、操作托盘和定位导丝。针吸活检设备用于从骨骼、肌肉、肝臟和肺部等各种器官采集组织和体液样本，并从体内提取细胞样本进行实验室分析。这些设备采用超音波引导切片检查、立体定位切片检查和磁振造影引导切片检查等引导技术。智慧切片检查设备应用于乳癌、皮肤癌、肝癌和摄护腺癌等多个领域。这些设备的最终用户包括医院、学术研究机构、诊断中心和影像中心。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

智慧切片检查设备研究报告是商业研究公司 (The Business 切片检查 Company) 最新报告系列之一，提供智慧切片检查设备市场统计数据，例如全球市场规模、区域份额、竞争对手的智慧切片检查设备市场份额、智慧切片检查设备细分市场的详细情况、市场趋势以及智慧活检设备行业的商机。这份智慧切片检查设备市场研究报告对该行业的现状和未来走势进行了详细分析，为您提供所需的全方位观点。

未来五年7.4%的预测成长率比我们先前对该市场的预测略有下降，下降了0.1%。这一下降主要源自于美国与其他国家之间关税的影响。这种影响可能会直接影响美国，导致微电子机械切割装置和即时影像感测器（主要从德国和日本进口）成本上升，从而导致精密组织采样程序的价格上涨。此外，由于互惠关税以及贸易紧张局势和限制措施升级对全球经济和贸易的负面影响，这种影响也将更加广泛地显现。

癌症发生率的上升预计将推动未来智慧切片检查设备市场的成长。癌症涵盖多种疾病，几乎可发生在体内任何器官或组织中，原因是异常细胞不受控制地增殖，突破正常界限，转移到其他器官或侵入邻近组织。癌症患者数量的增加推动了对精准、有针对性的组织样本的需求。这种需求推动了智慧切片检查设备的开发和改进，这些设备具有先进的分子、成像和精准功能，以支援诊断和治疗计划。例如，2024 年 1 月，总部位于瑞士的政府间组织世界卫生组织 (WHO) 预测，到 2050 年，全球新增癌症病例将超过 3,500 万例，比 2022 年记录的预计 2,000 万例和 970 万例死亡病例增加 77%。因此，癌症患者数量的增加正在推动智慧切片检查市场的成长。

微创手术的采用预计将显着促进智慧切片检查设备市场的成长。微创手术旨在最大限度地减少对正常身体结构的破坏，而使用智慧切片检查设备可以提高组织取样的精确度和准确度。这些设备通常采用先进的成像技术，例如超音波和核磁共振引导，使医护人员能够透过较小的切口针对特定区域进行切片检查。这减少了患者的创伤并提高了诊断的准确性。例如，根据经济合作暨发展组织2023 年 10 月发布的数据，捷克共和国的白内障手术数量预计将从 2021 年的 131,612 例增加 8.4%，到 2022 年增加到 142,670 例。因此，微创手术的日益普及正在推动智慧切片检查设备市场的发展。

智慧切片检查设备市场由提供切片检查样本采集、即时癌症组织表征、微创切片检查和精准组织定位等服务的营业单位所获得的收益组成。市场规模还包括服务提供者销售的或包含在其服务产品中的相关产品的价值。智慧切片检查设备市场还包括用于提供切片检查样本采集和即时癌症组织表征服务的影像引导切片检查设备、核心切片检查设备、骨骼切片穿刺针和设备以及分子切片检查设备的销售。此市场价值是“出厂价”，即商品製造商或生产商销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球智慧切片检查设备：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球智慧切片检查设备市场：成长率分析
  • 全球智慧切片检查设备市场表现：规模与成长，2019-2024
  • 全球智慧切片检查设备市场预测：规模与成长，2024-2029 年，2034 年
  • 全球智慧切片检查设备：总目标市场（TAM）

第六章 市场细分

  • 全球智慧切片检查设备市场（按产品、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 针切片检查切片装置
  • 治疗托盘
  • 本地化线路
  • 其他的
  • 全球智慧切片检查设备市场（按指导技术、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 超音波引导下切片检查
  • 立体定位引导切片检查
  • 磁振造影切片检查
  • 其他的
  • 全球智慧切片检查设备市场应用、效能及预测（2019-2024、2024-2029、2034）
  • 乳癌
  • 皮肤癌
  • 肝癌
  • 摄护腺癌
  • 其他的
  • 全球智慧切片检查设备市场（按最终用户、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 学术研究机构
  • 诊断和影像中心
  • 全球智慧切片检查设备市场：针切片检查设备细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 芯针切片装置
  • 细针抽吸（FNA）装置
  • 真空辅助切片检查装置
  • 全球智慧切片检查设备市场：手术托盘细分、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 预包装切片检查程序托盘
  • 可客製化的治疗托盘
  • 全球智慧切片检查设备市场：定位线细分、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 钩丝定位装置
  • 雷达定位装置
  • 磁定位装置
  • 全球智慧切片检查设备市场：其他细分市场、按类型、实际结果和预测，2019-2024 年、2024-2029 年、2034 年
  • 切片检查标记物
  • 切片检查成像系统
  • 切片检查引导系统

第七章 区域和国家分析

  • 全球智慧切片检查设备市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球智慧切片检查设备市场：国家、绩效及预测（2019-2024、2024-2029、2034）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 智慧切片检查设备市场：竞争格局
  • 智慧切片检查设备市场：公司简介
    • Cardinal Health Inc
    • General Electric Company
    • Medtronic Plc
    • Danaher Corporation
    • Canon Medical Systems Corporation

第31章：其他领先和创新企业

  • Toshiba Corporation
  • Siemens Healthineers
  • FUJIFILM Holdings Corporation
  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • B. Braun Melsungen AG
  • Olympus Corporation
  • Intuitive Surgical Inc.
  • Hologic Inc.
  • Cook Medical Inc.
  • CONMED Corporation
  • Leica Biosystems
  • Argon Medical Devices Inc.
  • Esaote SpA
  • SOMATEX Medical Technologies GmbH

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年智慧切片检查设备市场：提供新机会的国家
  • 2029 年智慧切片检查设备市场：细分市场将带来新机会
  • 2029年智慧切片检查设备市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r25310u

Smart biopsy devices are intelligent instruments designed to enhance the precision and efficiency of tissue sampling during medical procedures, often incorporating features such as image guidance, real-time feedback, or robotic assistance. These devices aim to improve diagnostic capabilities and patient outcomes, particularly in the context of cancer diagnosis and drug delivery.

The primary products within the category of smart biopsy devices include needle-based biopsy instruments, procedure trays, localization wires, and others. Needle-based biopsy instruments are tools used to extract a sample of the body's cells for laboratory analysis, collecting tissue or liquid samples from various organs such as bones, muscles, liver, and lungs. These devices employ guidance techniques such as ultrasound-guided biopsy, stereotactic-guided biopsy, magnetic resonance imaging-guided biopsy, and others. Smart biopsy devices find applications in various areas, including breast cancer, skin cancer, liver cancer, prostate cancer, and more. The end users of these devices include hospitals, academic and research institutes, as well as diagnostic and imaging centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The smart biopsy devices research report is one of a series of new reports from The Business Research Company that provides smart biopsy devices market statistics, including the smart biopsy devices industry's global market size, regional shares, competitors with smart biopsy devices market share, detailed smart biopsy devices market segments, market trends and opportunities, and any further data you may need to thrive in the smart biopsy devices industry. This smart biopsy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The smart biopsy devices market size has grown strongly in recent years. It will grow from $2.85 billion in 2024 to $3.01 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to increased cancer cases, demand for minimally invasive procedures, innovations in medical devices, improved diagnostic accuracy.

The smart biopsy devices market size is expected to see strong growth in the next few years. It will grow to $4.01 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to personalized medicine growth, advancements in imaging modalities, rise in biopsy for biomarker analysis, market entry of new players, enhanced data connectivity. Major trends in the forecast period include robot-assisted biopsies, ai-driven biopsy assistance, development of wireless biopsy tools, portable and handheld devices, real-time guidance systems.

The forecast of 7.4% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through increased costs for micro-electromechanical cutting mechanisms and real-time imaging sensors, primarily imported from Germany and Japan, leading to higher prices for precision tissue sampling procedures.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing incidence of cancer is anticipated to drive the growth of the smart biopsy devices market in the future. Cancer encompasses a wide range of diseases that can occur in nearly any organ or tissue in the body when abnormal cells grow uncontrollably, breach their usual boundaries, and either spread to other organs or invade nearby tissues. The rising number of cancer cases has led to a greater demand for precise and targeted tissue samples. This demand has spurred the development and enhancement of smart biopsy devices featuring advanced molecular, imaging, and precision capabilities to support diagnosis and treatment planning. For example, in January 2024, the World Health Organization, a Switzerland-based intergovernmental organization, projected that there will be over 35 million new cancer cases by 2050, representing a 77% increase from the estimated 20 million cases and 9.7 million deaths recorded in 2022. Therefore, the rising number of cancer cases is driving the growth of the smart biopsy device market.

The adoption of minimally invasive procedures is poised to contribute significantly to the growth of the smart biopsy devices market. Minimally invasive procedures, designed to minimize disruption to the body's normal structures, benefit from the use of smart biopsy devices to enhance precision and accuracy in tissue sampling. These devices often incorporate advanced imaging technologies such as real-time ultrasound or MRI guidance, enabling healthcare professionals to target specific areas for biopsy through smaller incisions. This reduces patient trauma and enhances diagnostic accuracy. For instance, data from the Organization for Economic Co-operation and Development in October 2023 revealed an 8.4% increase in cataract surgical procedures in the Czech Republic, totaling 142,670 procedures in 2022 compared to 131,612 in 2021. Therefore, the growing adoption of minimally invasive procedures is a driving factor in the smart biopsy devices market.

Major companies in the smart biopsy device market are developing advanced products, such as breast biopsy markers, to enhance the accuracy and effectiveness of breast cancer diagnostics. These markers are specifically designed to accurately identify the location of a tissue sample collected during a biopsy, assisting in future treatments and ensuring that the appropriate area is monitored for potential malignancy. For example, in August 2022, Mammotome, a US-based medical device company, introduced the Mammotome DualCore Dual Stage Core Biopsy System. This minimally invasive breast biopsy device employs a dual-stage process to deliver precise, high-quality tissue samples and is frequently used with ultrasound guidance to ensure accurate, safe, and efficient breast cancer diagnosis. Additionally, this system can be paired with advanced breast biopsy markers, providing clinicians with a comprehensive and innovative solution for ultrasound-guided breast biopsies.

Major companies in the smart biopsy devices market are introducing new products, such as dual-stage core biopsy instruments, to gain a competitive advantage. Dual-stage core biopsy involves a two-step process, starting with the acquisition stage, where the biopsy instrument is guided to obtain a tissue sample, followed by the extraction stage to retrieve the obtained tissue for diagnostic analysis. For instance, Mammotome, a breast cancer care solutions company, launched the Mammotome DualCore Dual Stage Core Biopsy System in August 2022. This advanced system offers three programmable firing modes and one-handed operation, providing clinicians with a versatile tool for accessing challenging lesions. The system's ergonomic design minimizes needle movements and vibrations, enhancing the overall patient experience.

In June 2023, Quest Diagnostics, a medical laboratories company, acquired Haystack Oncology for $450 million. This strategic acquisition enhances Quest Diagnostics' cancer diagnostics portfolio by incorporating Haystack's highly sensitive minimal-residual disease (MRD) testing technology based on circulating tumor DNA (ctDNA). The addition of Haystack's advanced testing capabilities allows Quest to offer improved early detection of solid tumor cancers through blood-based clinical lab services, starting in 2024. Haystack Oncology Inc. specializes in developing and utilizing advanced technologies for MRD testing in the field of cancer diagnostics.

Major companies operating in the smart biopsy devices market include Cardinal Health Inc, General Electric Company, Medtronic Plc, Danaher Corporation, Canon Medical Systems Corporation, Toshiba Corporation, Siemens Healthineers, FUJIFILM Holdings Corporation, Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc., Hologic Inc., Cook Medical Inc., CONMED Corporation, Leica Biosystems, Argon Medical Devices Inc., Esaote SpA, SOMATEX Medical Technologies GmbH, Planmed Oy, TSK Laboratory Europe B.V., DTR Medical Ltd., INRAD Inc., Sterylab Srl, EndoMed Systems GmbH

North America was the largest region in the smart biopsy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the smart biopsy devices market report during the forecast period. The regions covered in the smart biopsy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the smart biopsy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The smart biopsy devices market consists of revenues earned by entities by providing services such as collecting biopsy samples, real-time cancer tissue characterization, minimally invasive biopsy, and precise tissue targeting. The market value includes the value of related goods sold by the service provider or included within the service offering. The smart biopsy devices market also includes sales of image-guided biopsy devices, core biopsy devices, bone biopsy needles and devices, and molecular biopsy devices which are used in providing collecting biopsy samples, real-time cancer tissue characterization services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Smart Biopsy Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on smart biopsy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for smart biopsy devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The smart biopsy devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Needle-Based Biopsy Instruments; Procedure Trays; Localization Wires; Other Products
  • 2) By Guidance Technique: Ultrasound-Guided Biopsy; Stereotactic-Guided Biopsy; Magnetic Resonance Imaging-Guided Biopsy; Other Guidance Techniques
  • 3) By Application: Breast Cancer; Skin Cancer; Liver Cancer; Prostate Cancer; Other Applications
  • 4) By End-User: Hospitals; Academic And Research Institutes; Diagnostic And Imaging Centers
  • Subsegments:
  • 1) By Needle-Based Biopsy Instruments: Core Needle Biopsy Devices; Fine Needle Aspiration (FNA) Devices; Vacuum-Assisted Biopsy Devices
  • 2) By Procedure Trays: Pre-Packaged Biopsy Procedure Trays; Customizable Procedure Trays
  • 3) By Localization Wires: Hook Wire Localization Devices; Radar Localization Devices; Magnetic Localization Devices
  • 4) By Other Products: Biopsy Markers; Biopsy Imaging Systems; Biopsy Guidance Systems
  • Companies Mentioned: Cardinal Health Inc; General Electric Company; Medtronic Plc; Danaher Corporation; Canon Medical Systems Corporation; Toshiba Corporation; Siemens Healthineers; FUJIFILM Holdings Corporation; Becton Dickinson and Company; Boston Scientific Corporation; B. Braun Melsungen AG; Olympus Corporation; Intuitive Surgical Inc.; Hologic Inc.; Cook Medical Inc.; CONMED Corporation; Leica Biosystems; Argon Medical Devices Inc.; Esaote SpA; SOMATEX Medical Technologies GmbH; Planmed Oy; TSK Laboratory Europe B.V.; DTR Medical Ltd.; INRAD Inc.; Sterylab Srl; EndoMed Systems GmbH
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Smart Biopsy Devices Market Characteristics

3. Smart Biopsy Devices Market Trends And Strategies

4. Smart Biopsy Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Smart Biopsy Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Smart Biopsy Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Smart Biopsy Devices Market Growth Rate Analysis
  • 5.4. Global Smart Biopsy Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Smart Biopsy Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Smart Biopsy Devices Total Addressable Market (TAM)

6. Smart Biopsy Devices Market Segmentation

  • 6.1. Global Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Needle-Based Biopsy Instruments
  • Procedure Trays
  • Localization Wires
  • Other Products
  • 6.2. Global Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ultrasound-Guided Biopsy
  • Stereotactic-Guided Biopsy
  • Magnetic Resonance Imaging-Guided Biopsy
  • Other Guidance Techniques
  • 6.3. Global Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Breast Cancer
  • Skin Cancer
  • Liver Cancer
  • Prostate Cancer
  • Other Applications
  • 6.4. Global Smart Biopsy Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Academic And Research Institutes
  • Diagnostic And Imaging Centers
  • 6.5. Global Smart Biopsy Devices Market, Sub-Segmentation Of Needle-Based Biopsy Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Core Needle Biopsy Devices
  • Fine Needle Aspiration (FNA) Devices
  • Vacuum-Assisted Biopsy Devices
  • 6.6. Global Smart Biopsy Devices Market, Sub-Segmentation Of Procedure Trays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pre-Packaged Biopsy Procedure Trays
  • Customizable Procedure Trays
  • 6.7. Global Smart Biopsy Devices Market, Sub-Segmentation Of Localization Wires, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hook Wire Localization Devices
  • Radar Localization Devices
  • Magnetic Localization Devices
  • 6.8. Global Smart Biopsy Devices Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biopsy Markers
  • Biopsy Imaging Systems
  • Biopsy Guidance Systems

7. Smart Biopsy Devices Market Regional And Country Analysis

  • 7.1. Global Smart Biopsy Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Smart Biopsy Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Smart Biopsy Devices Market

  • 8.1. Asia-Pacific Smart Biopsy Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Smart Biopsy Devices Market

  • 9.1. China Smart Biopsy Devices Market Overview
  • 9.2. China Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Smart Biopsy Devices Market

  • 10.1. India Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Smart Biopsy Devices Market

  • 11.1. Japan Smart Biopsy Devices Market Overview
  • 11.2. Japan Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Smart Biopsy Devices Market

  • 12.1. Australia Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Smart Biopsy Devices Market

  • 13.1. Indonesia Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Smart Biopsy Devices Market

  • 14.1. South Korea Smart Biopsy Devices Market Overview
  • 14.2. South Korea Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Smart Biopsy Devices Market

  • 15.1. Western Europe Smart Biopsy Devices Market Overview
  • 15.2. Western Europe Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Smart Biopsy Devices Market

  • 16.1. UK Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Smart Biopsy Devices Market

  • 17.1. Germany Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Smart Biopsy Devices Market

  • 18.1. France Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Smart Biopsy Devices Market

  • 19.1. Italy Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Smart Biopsy Devices Market

  • 20.1. Spain Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Smart Biopsy Devices Market

  • 21.1. Eastern Europe Smart Biopsy Devices Market Overview
  • 21.2. Eastern Europe Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Smart Biopsy Devices Market

  • 22.1. Russia Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Smart Biopsy Devices Market

  • 23.1. North America Smart Biopsy Devices Market Overview
  • 23.2. North America Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Smart Biopsy Devices Market

  • 24.1. USA Smart Biopsy Devices Market Overview
  • 24.2. USA Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Smart Biopsy Devices Market

  • 25.1. Canada Smart Biopsy Devices Market Overview
  • 25.2. Canada Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Smart Biopsy Devices Market

  • 26.1. South America Smart Biopsy Devices Market Overview
  • 26.2. South America Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Smart Biopsy Devices Market

  • 27.1. Brazil Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Smart Biopsy Devices Market

  • 28.1. Middle East Smart Biopsy Devices Market Overview
  • 28.2. Middle East Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Smart Biopsy Devices Market

  • 29.1. Africa Smart Biopsy Devices Market Overview
  • 29.2. Africa Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Smart Biopsy Devices Market Competitive Landscape And Company Profiles

  • 30.1. Smart Biopsy Devices Market Competitive Landscape
  • 30.2. Smart Biopsy Devices Market Company Profiles
    • 30.2.1. Cardinal Health Inc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. General Electric Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Canon Medical Systems Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Smart Biopsy Devices Market Other Major And Innovative Companies

  • 31.1. Toshiba Corporation
  • 31.2. Siemens Healthineers
  • 31.3. FUJIFILM Holdings Corporation
  • 31.4. Becton Dickinson and Company
  • 31.5. Boston Scientific Corporation
  • 31.6. B. Braun Melsungen AG
  • 31.7. Olympus Corporation
  • 31.8. Intuitive Surgical Inc.
  • 31.9. Hologic Inc.
  • 31.10. Cook Medical Inc.
  • 31.11. CONMED Corporation
  • 31.12. Leica Biosystems
  • 31.13. Argon Medical Devices Inc.
  • 31.14. Esaote SpA
  • 31.15. SOMATEX Medical Technologies GmbH

32. Global Smart Biopsy Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Smart Biopsy Devices Market

34. Recent Developments In The Smart Biopsy Devices Market

35. Smart Biopsy Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Smart Biopsy Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Smart Biopsy Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Smart Biopsy Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer